Fuji Pharma CoFRA:FUP -2.59%88 Days Payable is 65.41 as of Mar. 2026, which is 32% below its 10-year median of 96.12. GuruFocus rates FRA:FUP with a GF Score™ of 88/100 and a GF Value™ of €9.59. The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, Fuji Pharma Co ranks worse than 64.67% on this metric.
The historical rank and industry rank for Fuji Pharma Co's Days Payable or its related term are showing as below:
FRA:FUP'
s Days Payable Range Over the Past 10 Years
Min: 51.42 Med: 96.12 Max: 109.3
Current: 64.94
During the past 13 years, Fuji Pharma Co's highest Days Payable was 109.30. The lowest was 51.42. And the median was 96.12.
FRA:FUP's Days Payable is ranked worse than 64.67% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs FRA:FUP: 64.94
Fuji Pharma Co's Days Payable
declined
from Mar. 2025 (99.32) to Mar. 2026 (65.41).
It may suggest that Fuji Pharma Coaccelerated paying its suppliers.
Fuji Pharma Co Days Payable Related Terms
Fuji Pharma Co Days Payable Historical Data
* Premium members only.
The historical data trend for Fuji Pharma Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fuji Pharma Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Fuji Pharma Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Fuji Pharma Co's Days Payable for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fuji Pharma Co (FRA:FUP) has a Days Payable of 65.41 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fuji Pharma Co and its competitors. This is 32% below median its historical median of 96.12. Over the past decade, Fuji Pharma Co's Days Payable has ranged from 51.42 to 109.30. According to the industry distribution chart, Fuji Pharma Co ranks #595 out of 920 companies in the Drug Manufacturers industry, placing it in the top 64.7%.
Is Fuji Pharma Co's Days Payable too high?
Fuji Pharma Co's current Days Payable of 65.41 is 32% below median its 10-year median of 96.12. Over the past 10 years, this metric has ranged from a low of 51.42 to a high of 109.30. The Drug Manufacturers industry median Days Payable is 90.84. Fuji Pharma Co's value of 65.41 is 28% below this industry median. Based on the distribution chart, Fuji Pharma Co ranks #595 out of 920 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fuji Pharma Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fuji Pharma Co ranks #595 out of 920 companies for Days Payable. This places Fuji Pharma Co in the lower half of its industry. The industry median Days Payable is 90.84. Fuji Pharma Co's value of 65.41 is 28% below this benchmark. Historically, Fuji Pharma Co's own Days Payable has ranged from 51.42 to 109.30 over the past decade. While the company's 10-year median is 96.12 vs. the industry median of 90.84, Fuji Pharma Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fuji Pharma Co's current Days Payable of 65.41 is 28% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fuji Pharma Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuji Pharma Co's current Days Payable is 65.41, which is 32% below median its own 10-year median of 96.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current Days Payable of 65.41. The stock's GF Value™ is €9.59, compared to a current price of €11.30 — trading 17.8% above its estimated fair value. The current Days Payable is 65.41, which is 32% below median its 10-year median of 96.12 and 28% below the Drug Manufacturers industry median of 90.84. Fuji Pharma Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current Days Payable is 65.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?
Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued.
The current stock price of €11.30 is trading 17.8% above its estimated GF Value™ of €9.59.
Key valuation signals for FRA:FUP:
Days Payable: 65.41 (32% below median its 10-year median of 96.12)
GF Value™: €9.59 vs. price of €11.30 (17.8% above fair value)
Industry Position: 28% below the Drug Manufacturers median (#595 of 920)
No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
88GF Score
Get the complete analysis for FRA:FUP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FUP has been successfully added to your 
